Elevance Health Surges 1.01% as $640M Volume Ranks 172nd in U.S. Trading Amid Sector-Driven Momentum

. 16, . stocks. The healthcare insurer’s performance reflected a mix of sector-specific dynamics and broader market sentiment, with no material news directly attributed to the stock on the day.

Analysts noted limited catalysts for the move, as regulatory updates or earnings guidance were absent from the public domain. The sector’s overall resilience amid macroeconomic uncertainty contributed to a defensive positioning trade, with investors rotating into healthcare names perceived as less sensitive to interest rate volatility.

Portfolio managers highlighted the stock’s liquidity profile as a key factor, given its consistent trading activity despite relatively modest market capitalization. Positioning in the sector remains cautious, with institutional investors balancing long-term value propositions against near-term valuation concerns.

To run this back-test accurately I need to pin down a few practical details: 1. Market universe • U.S. listed common stocks (NYSE + NASDAQ) – or a different market? 2. Entry/exit prices • Buy at the next day’s open and sell at that day’s close (typical daily-rebalance convention), • or buy at today’s close and sell at tomorrow’s close, etc.? 3. Portfolio construction & costs • Equal-weight each of the 500 names? • Any transaction-cost assumption you want applied? Let me know your preferences and I’ll build the back-test accordingly.